Salix Pharmaceuticals missed third-quarter earnings and sales forecasts and announced the sudden resignation of its chief financial officer, sending shares plunging late Thursday. Earlier, Akorn (AKRX) stock sold off on its messy Q3 results, but investors viewed its issues as mild, relatively, compared with its midsize pharma peer. Salix Pharmaceuticals (SLXP) reported after the close that earnings excluding one-time items rose 72%
Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week’s IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting earnings this week, including four pharma plays. Salix Pharmaceuticals (SLXP) has made headlines in recent months as both Allergan (AGN) and Actavis (ACT) have been rumored to be eyeing the gastrointestinal
Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week’s IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting earnings this week, including four pharma plays. Salix Pharmaceuticals (SLXP) has made headlines in recent months as both Allergan (AGN) and Actavis (ACT) have been rumored to be eyeing the gastrointestinal